ARK ETF Trust - ARK Genomic Revolution ETF (LON:0CQL)
25.00
-0.22 (-0.89%)
At close: Aug 25, 2025
LON:0CQL Holdings Information
LON:0CQL is an equity ETF with a total of 37 individual holdings. The top holdings are Tempus AI stock at 11.87%, CRISPR Therapeutics AG at 9.46%, Twist Bioscience at 5.83%, Recursion Pharmaceuticals at 5.33%, and Guardant Health at 4.73%.
Total Holdings
37
Top 10 Percentage
57.35%
Asset Class
Equity
ETF Category
Theme
Assets
745.48M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | TEM | Tempus AI, Inc. | 11.87% |
2 | CRSP | CRISPR Therapeutics AG | 9.46% |
3 | TWST | Twist Bioscience Corporation | 5.83% |
4 | RXRX | Recursion Pharmaceuticals, Inc. | 5.33% |
5 | GH | Guardant Health, Inc. | 4.73% |
6 | NTRA | Natera, Inc. | 4.46% |
7 | TXG | 10x Genomics, Inc. | 4.35% |
8 | ADPT | Adaptive Biotechnologies Corporation | 3.97% |
9 | PSNL | Personalis, Inc. | 3.68% |
10 | SDGR | Schrödinger, Inc. | 3.67% |
11 | ILMN | Illumina, Inc. | 3.51% |
12 | VCYT | Veracyte, Inc. | 3.40% |
13 | BEAM | Beam Therapeutics Inc. | 3.20% |
14 | ARCT | Arcturus Therapeutics Holdings Inc. | 2.93% |
15 | ABSI | Absci Corporation | 2.89% |
16 | NTLA | Intellia Therapeutics, Inc. | 2.87% |
17 | CDNA | CareDx, Inc | 2.70% |
18 | IONS | Ionis Pharmaceuticals, Inc. | 2.59% |
19 | PRME | Prime Medicine, Inc. | 1.54% |
20 | NRIX | Nurix Therapeutics, Inc. | 1.47% |
21 | PACB | Pacific Biosciences of California, Inc. | 1.42% |
22 | AMGN | Amgen Inc. | 1.33% |
23 | MASS | 908 Devices Inc. | 1.21% |
24 | INCY | Incyte Corporation | 1.20% |
25 | VEEV | Veeva Systems Inc. | 1.13% |
As of Aug 25, 2025